Kymera Therapeutics Inc. (KYMR)
Market Closed
16 Oct, 08:00 PM
NASDAQ (NMS) NASDAQ (NMS) Primary 
XKLS $
104. 78
-3.36
-3.1071%
$
9.25B Market Cap
- P/E Ratio
- Div Yield
488,700 Volume
-2.54 Eps
$ 108.14
Previous Close 
Want to track KYMR and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Kymera Therapeutics Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 William Staveacre Aster Capital Management (DIFC) Ltd. | 5,661 | $645,632.31 | $610,289.77 | -$35,342.54 | -5.47% |
 Bayforest Capital Ltd. Bayforest Capital Ltd. | 944 | $78,625.91 | $98,912.32 | $20,286.41 | 25.8% |
| BM Berkeley Meredith Hughes Financial Services LLC | 3 | $281.67 | $324.42 | $42.75 | 15.18% |
| EG Ethan Gilbert Rialto Wealth Management LLC | 9 | $888.67 | $973.26 | $84.59 | 9.52% |
| GFM GF Fund Management Co. Ltd. GF Fund Management Co. Ltd. | 1,729 | $82,878.39 | $181,545 | $98,666.61 | 119.05% |
| JCB John Ciaran Burns Universal-Beteiligungs- und Servicegesellschaft mbH | 89,494 | $3.68M | $9.68M | $6M | 162.91% |
 HFM Investment Advisors LLC HFM Investment Advisors LLC | 2 | $135 | $214.04 | $79.04 | 58.55% |
2026 © Marketlog. All Rights Reserved.
